Diabetes und rheumatische Erkrankungen in der Covid-19-Pandemie | Gelbe Liste
IJMS | Free Full-Text | Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Frontiers | Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
Decreased interleukin-35 levels and CD4+EBI3+ T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab)
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group - ScienceDirect
Linagliptin Diabetes Medikament Molekül (dipeptidyll peptidase 4 oder DPP4-Hemmer). Skelettmuskulatur Formel Stock-Vektorgrafik - Alamy
Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes | Genes & Immunity
Rituximab – Aktueller Stand – Ein Überblick — Deutsche Gesellschaft für ME/CFS
Fighting the uphill battle to cure type 1 diabetes - Lee - 2021 - Journal of Diabetes Investigation - Wiley Online Library
Current and future therapies for type 1 diabetes | SpringerLink
Rituximab Treatment Modulates the Release of Hydrogen Peroxide and the Production of Proinflammatory Cytokines by Monocyte at the Onset of Type 1 Diabetes | Bentham Science
Hypertonie und Diabetes als Risikofaktoren? – Rosenfluh.ch
Case Report: Faustdick hinter den Ohren - DocCheck
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes | SpringerLink
Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial - The Lancet Oncology
JCI Insight - Cell type–specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
B-cell depletion with CD20 (Rituximab). Anti-CD20 mAb can direct the... | Download Scientific Diagram
Warum Rituximab bei manchen Patienten mit CLL und anderen Lymphomen nicht so gut wirkt
PDF) Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: A case report
Rituximab - Wikipedia
PDF) Rituximab Selectively Suppresses Specific Islet Antibodies
POS1238 GLUCOCORTICOIDS, RITUXIMAB AND THE PRESENCE OF INTERSTITIAL LUNG DISEASE ARE ASSOCIATED WITH POOR OUTCOMES OF THE SARS-COV-2 INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE NATIONAL REGISTRY SAR-COVID. | Annals
Rituximab Selectively Suppresses Specific Islet Antibodies Trialnet-Yu et al Diabetes ppt download
Immunsuppressivum Rituximab erhöht Sterberisiko bei COVID-19 deutlich
